HCG: Healthcare Global Enterprises Limited has informed the Exchange about Appointment of interim Chief Financial Officer and Key Managerial Personnel of the Company. Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that, based on the recommendation of the Audit Committee and the Nomination and Remuneration Committee, the Board of Directors of the Company, at its meeting held on December 01, 2025, has approved the appointment of Dr. Manish Mattoo, Executive Director and Chief Executive Officer, as the interim Chief Financial Officer and Key Managerial Personnel of the Company in accordance with Section 203 of the Companies Act, 2013.The appointment shall be effective from December 01, 2025, and shall remain in force until a new Chief Financial Officer is appointed by the Board of Directors and assumes office as the Chief Financial Officer.
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Healthcare Global Enterprises (HCG) has appointed its existing Executive Director and CEO, Dr. Manish Mattoo, as the interim Chief Financial Officer (CFO) and Key Managerial Personnel, effective December 1, 2025. The appointment was approved by the Board based on recommendations from the Audit Committee and the Nomination and Remuneration Committee. This is a temporary arrangement that will remain in place until a new permanent CFO is appointed and takes office. The move suggests the previous CFO may have departed, though the announcement does not explicitly state this.
This is a transitional leadership change that may create short-term uncertainty, as the CEO is now handling dual responsibilities until a permanent CFO is found. Shareholders should watch for the formal appointment of a new CFO, which would signal stability in the finance function.